Peter Kappel - Burcon NutraScience Independent Director
| BU Stock | CAD 0.10 0.02 16.67% |
Director
Mr. Peter H. Kappel is Director of the Company. Mr. Kappel is a former investment banker who now manages a private investment portfolio. A former chartered accountant with KPMG in Vancouver and Frankfurt, he made the transition to investment banking with JP Morgan after business school. He also served in senior roles at Nomura, Dresdner Kleinwort Wasserstein, Calyon and DVB Bank in London. In the latter three, he was the managing director, in charge of their respective European securitization businesses. He was responsible for many groundbreaking transactions, a regular speaker at ABS conferences, and a founding and former executive committee member of the European securitization forum of the Bond Market Association. He holds an MBA from the Institut Europeen dAdministration des Affaires, a bachelor of arts in economics from the University of Victoria and received his chartered accountant designation through the Institute of Chartered Accountants of British Columbia. Mr. Kappel is on the board of Partnerships British Columbia, where he serves as audit committee chair. since 2016.
| Tenure | 8 years |
| Address | 1946 West Broadway, Vancouver, BC, Canada, V6J 1Z2 |
| Phone | 604 733 0896 |
| Web | https://www.burcon.ca |
Burcon NutraScience Management Efficiency
The company has return on total asset (ROA) of (0.3922) % which means that it has lost $0.3922 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5936) %, meaning that it generated substantial loss on money invested by shareholders. Burcon NutraScience's management efficiency ratios could be used to measure how well Burcon NutraScience manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of December 2024, Return On Tangible Assets is likely to drop to -0.67. In addition to that, Return On Capital Employed is likely to drop to -0.64. At this time, Burcon NutraScience's Non Currrent Assets Other are very stable compared to the past year. As of the 3rd of December 2024, Other Current Assets is likely to grow to about 826.5 K, while Total Assets are likely to drop about 10.9 M.Similar Executives
| Found 10 records | DIRECTOR Age | ||
| Michael McCain | Royal Bank of | 60 | |
| Bridget Kralingen | Royal Bank of | 55 | |
| David Denison | Royal Bank of | 66 | |
| Jeffery Yabuki | Royal Bank of | 59 | |
| Alice Laberge | Royal Bank of | 62 | |
| Heather MunroeBlum | Royal Bank of | 68 | |
| Thierry Vandal | Royal Bank of | 58 | |
| Jacynthe Cote | Royal Bank of | 60 | |
| Andrew Chisholm | Royal Bank of | 59 | |
| Toos Daruvala | Royal Bank of | 63 | |
Management Performance
| Return On Equity | -1.59 | ||||
| Return On Asset | -0.39 |
Burcon NutraScience Leadership Team
Elected by the shareholders, the Burcon NutraScience's board of directors comprises two types of representatives: Burcon NutraScience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Burcon. The board's role is to monitor Burcon NutraScience's management team and ensure that shareholders' interests are well served. Burcon NutraScience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Burcon NutraScience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randy Willardsen, Senior Vice President - Process | ||
| Johann Tergesen, President, Chief Executive Officer, Chief Operating Officer | ||
| Paul Lam, Director Relations | ||
| Kip MBA, Chief Officer | ||
| Dorothy Law, Senior Vice President - Legal, Corporate Secretary | ||
| Peter Kappel, Independent Director | ||
| Alan Chan, Independent Director | ||
| Debora Fang, Independent Director | ||
| MBA CFA, Chief Officer | ||
| Bradford Allen, Lead Independent Director | ||
| David Ju, Independent Director | ||
| Chi Ng, Director | ||
| John Gilpin, Independent Director | ||
| Martin Schweizer, Vice President - Technical Development | ||
| Kam Law, Senior Secretary | ||
| Rosanna Chau, Director | ||
| David Tyrrell, Independent Chairman of the Board | ||
| Jade Cheng, Chief Financial Officer, Treasurer | ||
| Calvin Ng, Director |
Burcon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Burcon NutraScience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.59 | ||||
| Return On Asset | -0.39 | ||||
| Operating Margin | (7.45) % | ||||
| Current Valuation | 18.96 M | ||||
| Shares Outstanding | 172.48 M | ||||
| Shares Owned By Insiders | 28.06 % | ||||
| Shares Owned By Institutions | 0.21 % | ||||
| Number Of Shares Shorted | 110.56 K | ||||
| Price To Earning | (5.20) X | ||||
| Price To Book | 2.97 X |
Pair Trading with Burcon NutraScience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burcon NutraScience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burcon NutraScience will appreciate offsetting losses from the drop in the long position's value.Moving against Burcon Stock
| 0.57 | FFH | Fairfax Financial | PairCorr |
| 0.51 | GS | GOLDMAN SACHS CDR | PairCorr |
| 0.41 | FFH-PD | Fairfax Financial | PairCorr |
| 0.4 | FFH-PM | Fairfax Financial | PairCorr |
The ability to find closely correlated positions to Burcon NutraScience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burcon NutraScience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burcon NutraScience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burcon NutraScience to buy it.
The correlation of Burcon NutraScience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burcon NutraScience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burcon NutraScience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burcon NutraScience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Burcon Stock
Burcon NutraScience financial ratios help investors to determine whether Burcon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Burcon with respect to the benefits of owning Burcon NutraScience security.